Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
164.83
+4.00 (2.49%)
Dec 20, 2024, 4:00 PM EST - Market closed
Krystal Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4,741 | 3,499 | 2,040 | 1,742 | 1,182 | 959 | |
| Market Cap Growth | 61.05% | 71.56% | 17.08% | 47.34% | 23.36% | 219.69% | |
| Enterprise Value | 4,054 | 2,909 | 1,642 | 1,388 | 899 | 759 | |
| Last Close Price | 164.83 | 124.06 | 79.22 | 69.95 | 60.00 | 55.38 | |
| PE Ratio | 92.96 | 320.09 | - | - | - | - | |
| PS Ratio | 19.41 | 69.02 | - | - | - | - | |
| PB Ratio | 5.35 | 4.49 | 3.91 | 2.94 | 4.05 | 4.72 | |
| P/TBV Ratio | 5.90 | 4.49 | 3.91 | 2.94 | 4.05 | 4.72 | |
| EV/Sales Ratio | 16.78 | 57.38 | - | - | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | |
| Asset Turnover | 0.27 | 0.07 | - | - | - | - | |
| Quick Ratio | 7.66 | 17.35 | 13.14 | 17.02 | 17.56 | 58.22 | |
| Current Ratio | 7.97 | 17.76 | 13.30 | 17.18 | 17.80 | 58.88 | |
| Return on Equity (ROE) | 6.38% | 1.68% | -25.09% | -15.71% | -13.00% | -12.08% | |
| Return on Assets (ROA) | 4.58% | -8.83% | -12.80% | -9.32% | -7.93% | -8.49% | |
| Return on Capital (ROIC) | 4.90% | -9.22% | -13.38% | -9.73% | -8.21% | -8.64% | |
| Earnings Yield | 1.10% | 0.31% | -6.86% | -3.99% | -2.72% | -1.99% | |
| FCF Yield | 1.22% | -2.87% | -7.53% | -6.67% | -3.46% | -2.62% | |
| Buyback Yield / Dilution | -11.06% | -8.87% | -14.84% | -18.15% | -18.15% | -41.93% | |
| Total Shareholder Return | -11.06% | -8.87% | -14.84% | -18.15% | -18.15% | -41.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.